Home / Investors / Startups / RapidAI

RapidAI

RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients.

About RapidAI

RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients. RapidAI's platform uses artificial intelligence to create advanced images from non-contrast CT, CT Angiography, CT perfusion, and MRI diffusion and perfusion scans. It was founded in 2011 and headquartered in Menlo Park, California.

Industries

Investors in RapidAI (1)